| Mrs Homecare Of Americus | |
| 710 S Martin Luther King Blvd, Americus, Georgia 31719 | |
| (229) 928-2701 |
| Name | Mrs Homecare Of Americus |
|---|---|
| Organization Name | Mrs Homecare, Inc. |
| Location | 710 S Martin Luther King Blvd, Americus, Georgia 31719 |
| Type | DME Supplier - Oxygen Equipment & Supplies |
| Phone | (229) 928-2701 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
University of Alabama at Birmingham researchers report the first documentation that suppressing a key cell-signaling pathway in a rat model of Parkinson's disease reduces pathogenesis. Oral administration of AZD1480 — one of the JAK/STAT pathway inhibitors generally known as Jakinibs — lessened the destructive inflammation and nerve cell degradation in the area of the brain affected by Parkinson's.
People with cancer who develop COVID-19 are much more likely to die from the disease than those without cancer, according to physician-researchers at Montefiore Health System and Albert Einstein College of Medicine.
The prevalence of cannabis, or marijuana, use in the United States increased from 2005 to 2017 among persons with and without depression and was approximately twice as common among those with depression in 2017.
Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved JUVISYNC(sitagliptin and simvastatin), a new treatment for type 2 diabetes that combines the glucose-lowering medication sitagliptin, the active component of JANUVIA (sitagliptin), with the cholesterol-lowering medication ZOCOR.
› Verified 4 days ago
| NPI Number | 1649273962 |
| Organization Name | MRS HOMECARE, INC. |
| Doing Business As | MRS OF AMERICUS |
| Type | DME Supplier - Oxygen Equipment & Supplies |
| Address | 710 S Martin Luther King Jr Blvd, Americus, GA 31719 |
| Phone Number | 229-928-2701 |
News Archive
University of Alabama at Birmingham researchers report the first documentation that suppressing a key cell-signaling pathway in a rat model of Parkinson's disease reduces pathogenesis. Oral administration of AZD1480 — one of the JAK/STAT pathway inhibitors generally known as Jakinibs — lessened the destructive inflammation and nerve cell degradation in the area of the brain affected by Parkinson's.
People with cancer who develop COVID-19 are much more likely to die from the disease than those without cancer, according to physician-researchers at Montefiore Health System and Albert Einstein College of Medicine.
The prevalence of cannabis, or marijuana, use in the United States increased from 2005 to 2017 among persons with and without depression and was approximately twice as common among those with depression in 2017.
Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved JUVISYNC(sitagliptin and simvastatin), a new treatment for type 2 diabetes that combines the glucose-lowering medication sitagliptin, the active component of JANUVIA (sitagliptin), with the cholesterol-lowering medication ZOCOR.
› Verified 4 days ago
News Archive
University of Alabama at Birmingham researchers report the first documentation that suppressing a key cell-signaling pathway in a rat model of Parkinson's disease reduces pathogenesis. Oral administration of AZD1480 — one of the JAK/STAT pathway inhibitors generally known as Jakinibs — lessened the destructive inflammation and nerve cell degradation in the area of the brain affected by Parkinson's.
People with cancer who develop COVID-19 are much more likely to die from the disease than those without cancer, according to physician-researchers at Montefiore Health System and Albert Einstein College of Medicine.
The prevalence of cannabis, or marijuana, use in the United States increased from 2005 to 2017 among persons with and without depression and was approximately twice as common among those with depression in 2017.
Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved JUVISYNC(sitagliptin and simvastatin), a new treatment for type 2 diabetes that combines the glucose-lowering medication sitagliptin, the active component of JANUVIA (sitagliptin), with the cholesterol-lowering medication ZOCOR.
› Verified 4 days ago
Doctor's Pharmacy Type: Community/Retail Pharmacy Location: 611-b East Lamar St, Americus, Georgia 31709 Phone: (229) 928-9010 | |
Food Lion Pharmacy #2222 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 107 Prince Street, Americus, Georgia 31709 Phone: (229) 931-6312 | |
Cvs Pharmacy # 04672 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1036 E Forsyth Street, Americus, Georgia 31709 Phone: (229) 924-6916 | |
Hart Eye Care Pc Type: Medicare Supplier Location: 135 Ga Highway 27 E, Americus, Georgia 31709 Phone: (229) 928-2024 | |
Limbcare Prosthetics & Orthotics Of Type: Prosthetic/Orthotic Supplier Location: 511 W Forsyth St, Americus, Georgia 31709 Phone: (229) 924-1620 |